BROOKFIELD, Wis., Sept. 30 /PRNewswire-FirstCall/ — Honeywell HomMed LifeStream(TM) Remote Patient Care System has been selected by Carolinas HealthCare System for its new network-wide telemonitoring program. As part of its implementation of the LifeStream(TM) System, Carolinas HealthCare System purchased 360 Genesis(R) DM Telehealth Monitors for the program, running across six counties, which aims to improve patient outcomes, reduce rehospitalizations and decrease the duration of hospital stays for patients.
The Genesis(R) DM, a 2008 gold winner of the Medical Design Excellence Award, is specifically designed to be integrated with the Web-based LifeStream(R) system and contains one of the most comprehensive and easy-to-use remote biometric and symptom evaluations available. Honeywell’s Remote Patient Care System is part of HomMed’s LifeStream(TM) ecosystem, a comprehensive telehealth platform which integrates patient facing devices; software applications and disease management content; and related services to provide a total telehealth solution optimizing patient and financial outcomes, while improving standardization and quality of care.
“When used as part of a comprehensive program like Carolinas HealthCare System’s, the innovative technologies of the LifeStream(TM) Remote Patient Care System and, the Genesis(R) DM Telehealth Monitor, enable better outcomes for patients through regular monitoring and preventive intervention,” said Terry Duesterhoeft, vice president of sales and marketing for Honeywell HomMed. “Additionally, these technologies help reduce escalating healthcare costs by reducing the amount of time patients may spend in hospitals and managing their re-entry.”
Carolinas HealthCare System, an integrated delivery network (IDN) of 23 hospitals throughout North and South Carolina, is currently rolling out the telemonitoring program. It will be used by hospitals in the IDN with home care services including Carolinas Medical Center in Charlotte, NC; Carolinas Medical Center — Lincoln in Lincolnton, NC; Carolinas Medical Center — Union in Monroe, NC; Cleveland Regional Medical Center in Shelby, NC; Wilkes Regional Medical Center in North Wilkesboro, NC; and Blue Ridge HealthCare System in Valdese, NC.
“Our new telehealth monitoring program will improve readmission rates, reduce the number of visits per episode and increase efficiency across our expanding network geography,” said Connie Bonebrake, vice president for Post Acute Care Services, Carolinas HealthCare System. “Having all the agencies of Carolinas HealthCare System using the same Honeywell System will allow us to share our expertise and experiences, compare results and leverage the successes of the program throughout the region.”
Most patients in the telehealth monitoring program suffer from chronic conditions, such as congestive heart failure, hypertension, diabetes or other chronic conditions. These patients are set up with an in-home Genesis(R) DM Telehealth Monitor, which measures information such as weight, blood pressure, and any daily change in health conditions. This information is transferred securely from the home monitor to the patient’s health care provider for analysis and identification of any potential problems.
“In a pilot program, a patient who was regularly admitted to the hospital experienced no additional readmissions after one year on the monitor,” said Marla Nutting, administrator for Blue Ridge Home HealthCare in the Carolinas HealthCare System. “This wasn’t an isolated success. Over the last five years, working with the Honeywell System has generated a return on investment of 500 percent for us, when considering the costs that would have incurred from readmissions and the savings generated by improved care and efficiency.”
For more information about Honeywell HomMed’s Remote Patient Care System, visit http://www.hommed.com/.
Honeywell International is a $38 billion diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell’s shares are traded on the New York, London and Chicago Stock Exchanges. For additional information, please visit http://www.honeywell.com/.
This release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on management’s assumptions and assessments in light of past experience and trends, current conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by our forward-looking statements. Our forward-looking statements are also subject to risks and uncertainties, which can affect our performance in both the near- and long-term. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.
Photo: http://www.newscom.com/cgi-bin/prnh/20071030/AQTU029LOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, [email protected]
CONTACT: Herly Karlen of Honeywell International, +1-262-252-5847,[email protected]
Web site: http://www.honeywell.com/http://www.hommed.com/